Healthcare provider profile · identity verified

Michael P Fuller, MD

Internal Medicine · SAINT LOUIS, MO · NPI 1194732842

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1308	366
Levothyroxine Sodium	Levothyroxine Sodium	600	149
Amlodipine Besylate	Amlodipine Besylate	529	148
Lisinopril	Lisinopril	499	142
Losartan Potassium	Losartan Potassium	403	113
Metoprolol Succinate	Metoprolol Succinate	341	93
Rosuvastatin Calcium	Rosuvastatin Calcium	301	89
Omeprazole	Omeprazole	300	92
Simvastatin	Simvastatin	295	74
Metformin Hcl	Metformin Hcl	287	77
Gabapentin	Gabapentin	248	72
Tamsulosin Hcl	Tamsulosin Hcl	230	67
Eliquis	Apixaban	200	50
Arexvy	Rsvpref3 Antigen/As01e/Pf	179	179
Pantoprazole Sodium	Pantoprazole Sodium	179	56
Ozempic	Semaglutide	176	29
Escitalopram Oxalate	Escitalopram Oxalate	166	45
Allopurinol	Allopurinol	141	41
Glimepiride	Glimepiride	129	33
Jardiance	Empagliflozin	129	31
Pravastatin Sodium	Pravastatin Sodium	129	36
Chlorthalidone	Chlorthalidone	127	38
Valsartan	Valsartan	126	38
Irbesartan	Irbesartan	123	33
Albuterol Sulfate Hfa	Albuterol Sulfate	112	36
Hydrochlorothiazide	Hydrochlorothiazide	108	34
Fluticasone Propionate	Fluticasone Propionate	104	45
Furosemide	Furosemide	103	38
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	101	31
Potassium Chloride	Potassium Chloride	99	25
Metoprolol Tartrate	Metoprolol Tartrate	97	34
Ibandronate Sodium	Ibandronate Sodium	95	30
Clopidogrel	Clopidogrel Bisulfate	94	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	93	26
Sertraline Hcl	Sertraline Hcl	93	25
Carvedilol	Carvedilol	84	26
Montelukast Sodium	Montelukast Sodium	80	24
Finasteride	Finasteride	78	20
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	74	17
Spironolactone	Spironolactone	72	23
Prednisone	Prednisone	71	34
Ezetimibe	Ezetimibe	70	18
Metformin Hcl Er	Metformin Hcl	70	24
Trazodone Hcl	Trazodone Hcl	67	20
Venlafaxine Hcl Er	Venlafaxine Hcl	67	18
Duloxetine Hcl	Duloxetine Hcl	63	18
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	62	17
Vitamin D2	Ergocalciferol (Vitamin D2)	60	21
Warfarin Sodium	Warfarin Sodium	58	12
Famotidine	Famotidine	52	15
Paroxetine Hcl	Paroxetine Hcl	48	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	47	14
Triamcinolone Acetonide	Triamcinolone Acetonide	47	24
Fluoxetine Hcl	Fluoxetine Hcl	46	17
Pregabalin	Pregabalin	46	14
Hydralazine Hcl	Hydralazine Hcl	44	15
Doxazosin Mesylate	Doxazosin Mesylate	43	11
Alprazolam	Alprazolam	42	18
Januvia	Sitagliptin Phosphate	40	suppressed
Tramadol Hcl	Tramadol Hcl	39	19
Ventolin Hfa	Albuterol Sulfate	39	suppressed
Citalopram Hbr	Citalopram Hydrobromide	38	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	38	11
Glipizide Er	Glipizide	37	suppressed
Synthroid	Levothyroxine Sodium	37	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	36	19
Klor-Con M20	Potassium Chloride	36	suppressed
Mirtazapine	Mirtazapine	36	11
Bupropion Xl	Bupropion Hcl	35	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	35	suppressed
Xarelto	Rivaroxaban	35	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	34	suppressed
Atenolol	Atenolol	33	suppressed
Baclofen	Baclofen	33	suppressed
Sildenafil Citrate	Sildenafil Citrate	32	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	31	suppressed
Torsemide	Torsemide	31	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	30	suppressed
Donepezil Hcl	Donepezil Hcl	30	suppressed
Cephalexin	Cephalexin	29	25
Pioglitazone Hcl	Pioglitazone Hcl	28	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	28	suppressed
Dilt-Xr	Diltiazem Hcl	27	suppressed
Celecoxib	Celecoxib	26	suppressed
Flecainide Acetate	Flecainide Acetate	26	suppressed
Breo Ellipta	Fluticasone/Vilanterol	25	suppressed
Humalog Kwikpen U-100	Insulin Lispro	25	suppressed
Benazepril Hcl	Benazepril Hcl	24	suppressed
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Acyclovir	Acyclovir	23	suppressed
Buspirone Hcl	Buspirone Hcl	23	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	23	suppressed
Dutasteride	Dutasteride	23	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	23	suppressed
Folic Acid	Folic Acid	23	suppressed
Midodrine Hcl	Midodrine Hcl	23	suppressed
Ramipril	Ramipril	23	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	22	19
Hydrocortisone	Hydrocortisone	21	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	21	21
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	21	suppressed
Mounjaro	Tirzepatide	20	suppressed
Nystatin	Nystatin	20	suppressed
Phenobarbital	Phenobarbital	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	18
Glipizide	Glipizide	19	suppressed
Meloxicam	Meloxicam	19	11
Entresto	Sacubitril/Valsartan	18	suppressed
Azithromycin	Azithromycin	17	16
Bumetanide	Bumetanide	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Sotalol	Sotalol Hcl	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Colchicine	Colchicine	15	14
Fyavolv	Norethindrone Ac/Eth Estradiol	15	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	15	suppressed
Spiriva Handihaler	Tiotropium Bromide	15	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	12
Testosterone Cypionate	Testosterone Cypionate	14	suppressed
Amiloride Hcl	Amiloride Hcl	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Labetalol Hcl	Labetalol Hcl	13	suppressed
Rybelsus	Semaglutide	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Estradiol	Estradiol	12	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Methimazole	Methimazole	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	11	suppressed
Cholestyramine	Cholestyramine (With Sugar)	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error